The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Asthma Therapeutics Market Insights and Sales Trends 2025

Asthma Therapeutics Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1812268

No of Pages : 114

Ask Your Query

Synopsis

The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parenteral segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Asthma Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Asthma Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Asthma Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Asthma Therapeutics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Asthma Therapeutics covered in this report include AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, Merck, Horizon Pharma, Mitsubishi Tanabe Pharma, Sanofi and Mundipharma, etc.
The global Asthma Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • AstraZeneca
  • Boehringer Ingelheim
  • F. Hoffmann-La Roche
  • GSK
  • Merck
  • Horizon Pharma
  • Mitsubishi Tanabe Pharma
  • Sanofi
  • Mundipharma
  • Nycomed
  • Kissei Pharmaceutical
  • ALK-Abello
  • Array BioPharma
  • SAMA Pharmaceuticals
  • Whanin Pharmaceutical

Global Asthma Therapeutics market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Asthma Therapeutics market, Segment by Type:

  • Inhalation
  • Parenteral
  • Oral

Global Asthma Therapeutics market, by Application

  • Hospitals
  • Clinics

Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Asthma Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Asthma Therapeutics
1.1 Asthma Therapeutics Market Overview
1.1.1 Asthma Therapeutics Product Scope
1.1.2 Asthma Therapeutics Market Status and Outlook
1.2 Global Asthma Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Asthma Therapeutics Market Size by Region (2018-2029)
1.4 Global Asthma Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Asthma Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Asthma Therapeutics Market Size (2018-2029)
1.6.1 North America Asthma Therapeutics Market Size (2018-2029)
1.6.2 Europe Asthma Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Asthma Therapeutics Market Size (2018-2029)
1.6.4 Latin America Asthma Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Asthma Therapeutics Market Size (2018-2029)
2 Asthma Therapeutics Market by Type
2.1 Introduction
2.1.1 Inhalation
2.1.2 Parenteral
2.1.3 Oral
2.2 Global Asthma Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Asthma Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Asthma Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Asthma Therapeutics Revenue Breakdown by Type (2018-2029)
3 Asthma Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Asthma Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Asthma Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Asthma Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Asthma Therapeutics Revenue Breakdown by Application (2018-2029)
4 Asthma Therapeutics Competition Analysis by Players
4.1 Global Asthma Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Asthma Therapeutics as of 2022)
4.3 Date of Key Players Enter into Asthma Therapeutics Market
4.4 Global Top Players Asthma Therapeutics Headquarters and Area Served
4.5 Key Players Asthma Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Asthma Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Profile
5.1.2 AstraZeneca Main Business
5.1.3 AstraZeneca Asthma Therapeutics Products, Services and Solutions
5.1.4 AstraZeneca Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 AstraZeneca Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Asthma Therapeutics Products, Services and Solutions
5.2.4 Boehringer Ingelheim Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 F. Hoffmann-La Roche
5.3.1 F. Hoffmann-La Roche Profile
5.3.2 F. Hoffmann-La Roche Main Business
5.3.3 F. Hoffmann-La Roche Asthma Therapeutics Products, Services and Solutions
5.3.4 F. Hoffmann-La Roche Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 GSK Recent Developments
5.4 GSK
5.4.1 GSK Profile
5.4.2 GSK Main Business
5.4.3 GSK Asthma Therapeutics Products, Services and Solutions
5.4.4 GSK Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 GSK Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Asthma Therapeutics Products, Services and Solutions
5.5.4 Merck Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Recent Developments
5.6 Horizon Pharma
5.6.1 Horizon Pharma Profile
5.6.2 Horizon Pharma Main Business
5.6.3 Horizon Pharma Asthma Therapeutics Products, Services and Solutions
5.6.4 Horizon Pharma Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Horizon Pharma Recent Developments
5.7 Mitsubishi Tanabe Pharma
5.7.1 Mitsubishi Tanabe Pharma Profile
5.7.2 Mitsubishi Tanabe Pharma Main Business
5.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Products, Services and Solutions
5.7.4 Mitsubishi Tanabe Pharma Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Mitsubishi Tanabe Pharma Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Asthma Therapeutics Products, Services and Solutions
5.8.4 Sanofi Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
5.9 Mundipharma
5.9.1 Mundipharma Profile
5.9.2 Mundipharma Main Business
5.9.3 Mundipharma Asthma Therapeutics Products, Services and Solutions
5.9.4 Mundipharma Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Mundipharma Recent Developments
5.10 Nycomed
5.10.1 Nycomed Profile
5.10.2 Nycomed Main Business
5.10.3 Nycomed Asthma Therapeutics Products, Services and Solutions
5.10.4 Nycomed Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Nycomed Recent Developments
5.11 Kissei Pharmaceutical
5.11.1 Kissei Pharmaceutical Profile
5.11.2 Kissei Pharmaceutical Main Business
5.11.3 Kissei Pharmaceutical Asthma Therapeutics Products, Services and Solutions
5.11.4 Kissei Pharmaceutical Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Kissei Pharmaceutical Recent Developments
5.12 ALK-Abello
5.12.1 ALK-Abello Profile
5.12.2 ALK-Abello Main Business
5.12.3 ALK-Abello Asthma Therapeutics Products, Services and Solutions
5.12.4 ALK-Abello Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 ALK-Abello Recent Developments
5.13 Array BioPharma
5.13.1 Array BioPharma Profile
5.13.2 Array BioPharma Main Business
5.13.3 Array BioPharma Asthma Therapeutics Products, Services and Solutions
5.13.4 Array BioPharma Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Array BioPharma Recent Developments
5.14 SAMA Pharmaceuticals
5.14.1 SAMA Pharmaceuticals Profile
5.14.2 SAMA Pharmaceuticals Main Business
5.14.3 SAMA Pharmaceuticals Asthma Therapeutics Products, Services and Solutions
5.14.4 SAMA Pharmaceuticals Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 SAMA Pharmaceuticals Recent Developments
5.15 Whanin Pharmaceutical
5.15.1 Whanin Pharmaceutical Profile
5.15.2 Whanin Pharmaceutical Main Business
5.15.3 Whanin Pharmaceutical Asthma Therapeutics Products, Services and Solutions
5.15.4 Whanin Pharmaceutical Asthma Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Whanin Pharmaceutical Recent Developments
6 North America
6.1 North America Asthma Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Asthma Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Asthma Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Asthma Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Asthma Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Asthma Therapeutics Market Dynamics
11.1 Asthma Therapeutics Industry Trends
11.2 Asthma Therapeutics Market Drivers
11.3 Asthma Therapeutics Market Challenges
11.4 Asthma Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock